A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
I8F-MC-GPHU - ClinicalTrials.gov - NCT04407234
The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/very overweight participants. Participants include those without diabetes and those with type 2 diabetes.
Trial Summary
Age Range
18 - 65 yearsConditions the trial is for
Type 2 Diabetes, ObesityWhat the trial is testing?
Acetaminophen, TirzepatideCould I receive a Placebo?
NoEnrollment Goal
36Trial Dates
Sep 15, 2020 - Jan 7, 2021How long will I be in the trial?
Participation will last about 13 weeks, including screening.Trial Phase
ILilly Trial Alerts
Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
You will complete the questionnaire on another website.YesNo